Back to Search
ELLEN CONNER, MD
MD
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) Physician
NPI: 1609867100IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gynecology Physician
Obstetrics & Gynecology — Gynecology
Code: 207VG0400X
25MA07702900(NJ)
Gynecologic Oncology Physician
Obstetrics & Gynecology — Gynecologic Oncology
Code: 207VX0201X
25MA07702900(NJ)
Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) PhysicianPrimary
Obstetrics & Gynecology — Urogynecology and Reconstructive Pelvic Surgery
Code: 207VF0040X
25MA07702900(NJ)
CMS Specialties
PrimaryOBSTETRICS/GYNECOLOGY
Education
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
Class of 1998
Research & Publications (20)
Vaginal delivery and serum markers of ischemia/reperfusion injury.
PMID 16769072·Int J Gynaecol Obstet·2006
8-other
Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury.
PMID 18670758·Intensive Care Med·2009
6-review
Central role of c-Myc during malignant conversion in human hepatocarcinogenesis.
PMID 19276364·Cancer Res·2009
8-other
The effect of etanercept on the human cutaneous allergic response.
PMID 18206514·J Allergy Clin Immunol·2008
3-trial
Proteomic and metabolomic biomarkers for III-V semiconductors: and prospects for application to nano-materials.
PMID 18353413·Toxicol Appl Pharmacol·2008
4-observational
Hepatocyte-specific c-Met deletion disrupts redox homeostasis and sensitizes to Fas-mediated apoptosis.
PMID 18348981·J Biol Chem·2008
7-preclinical
E2F1 inhibits c-Myc-driven apoptosis via PIK3CA/Akt/mTOR and COX-2 in a mouse model of human liver cancer.
PMID 18722373·Gastroenterology·2008
7-preclinical
Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma.
PMID 17717605·J Clin Invest·2007
8-other
Loss of hepatocyte growth factor/c-Met signaling pathway accelerates early stages of N-nitrosodiethylamine induced hepatocarcinogenesis.
PMID 17942915·Cancer Res·2007
7-preclinical
Serum proprotein convertase subtilisin kexin type 9 is correlated directly with serum LDL cholesterol.
PMID 17702855·Clin Chem·2007
8-other
Oncogene-specific gene expression signatures at preneoplastic stage in mice define distinct mechanisms of hepatocarcinogenesis.
PMID 17006931·Hepatology·2006
7-preclinical
Emerging therapeutic options for atopic dermatitis: beyond TIMs.
PMID 16822379·Curr Allergy Asthma Rep·2006
6-review
Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.
PMID 16618406·Gastroenterology·2006
8-other
Metabolomic and proteomic biomarkers for III-V semiconductors: chemical-specific porphyrinurias and proteinurias.
PMID 15967200·Toxicol Appl Pharmacol·2005
7-preclinical
Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer.
PMID 15885355·J Hepatol·2005
7-preclinical
The immunoglobulin E receptor: expression and regulation.
PMID 15842956·Curr Allergy Asthma Rep·2005
6-review
Intact signaling by transforming growth factor beta is not required for termination of liver regeneration in mice.
PMID 15389868·Hepatology·2004
7-preclinical
Disregulation of E-cadherin in transgenic mouse models of liver cancer.
PMID 15220935·Lab Invest·2004
7-preclinical
Disruption of beta-catenin pathway or genomic instability define two distinct categories of liver cancer in transgenic mice.
PMID 15131798·Gastroenterology·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 19 DAVIS AVE FL 7
NEPTUNE, NJ 07753 - Phone
- (732) 776-3797
Quick Facts
- NPI
- 1609867100
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 28
- Publications
- 20
Are you this provider?
Claim Your Profile